Exact Sciences
EXAS
#1714
Rank
NZ$16.83 B
Marketcap
$90.94
Share price
0.70%
Change (1 day)
-15.48%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Cash on Hand

Cash on Hand as of September 2024 : NZ$1.74 Billion

According to Exact Sciences's latest financial reports the company has NZ$1.74 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Exact Sciences - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$1.22 B23.52%
2022-12-31NZ$0.99 B-34.01%
2021-12-31NZ$1.50 B-40.84%
2020-12-31NZ$2.55 B430.63%
2019-12-31NZ$0.48 B-71.33%
2018-12-31NZ$1.67 B180.25%
2017-12-31NZ$0.59 B33.15%
2016-12-31NZ$0.44 B0.16%
2015-12-31NZ$0.44 B24.25%
2014-12-31NZ$0.36 B122.54%
2013-12-31NZ$0.16 B23.38%
2012-12-31NZ$0.13 B9.87%
2011-12-31NZ$0.11 B-3.28%
2010-12-31NZ$0.12 B269.24%
2009-12-31NZ$33.49 M293.71%
2008-12-31NZ$8.5 M-48.23%
2007-12-31NZ$16.43 M-45.07%
2006-12-31NZ$29.91 M-40.07%
2005-12-31NZ$49.91 M-29.16%
2004-12-31NZ$70.46 M64.73%
2003-12-31NZ$42.77 M-48.94%
2002-12-31NZ$83.77 M-38.8%
2001-12-31NZ$0.13 B129.17%
2000-12-31NZ$59.73 M778.5%
1999-12-31NZ$6.79 M-59.4%
1998-12-31NZ$16.74 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.16 B-90.47%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.46 B-73.16%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.36 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.48 B 613.34%๐Ÿ‡ซ๐Ÿ‡ท France